Literature for inhibitor I17.950: secretory leukocyte peptidase inhibitor domain 1

2008
1. Nishimura,J., Saiga,H., Sato,S., Okuyama,M., Kayama,H., Kuwata,H., Matsumoto,S., Nishida,T., Sawa,Y., Akira,S., Yoshikai,Y., Yamamoto,M. and Takeda,K.
   Potent antimycobacterial activity of mouse secretory leukocyte protease inhibitor
   J Immunol180, 4032-4039. PubMed  Europe PubMed
1995
2. Masuda,K., Kamimura,T., Watanabe,K., Suga,T., Kanesaki,M., Takeuchi,A., Imaizumi,A. and Suzuki,Y.
   Pharmacological activity of the C-terminal and N-terminal domains of secretory leukoprotease inhibitor in vitro
   Br J Pharmacol115, 883-888. PubMed  Europe PubMed
1991
3. [YEAR:30-9-1991]Van-Seuningen,I. and Davril,M.
   Separation of the two domains of human mucus proteinase inhibitor: inhibitory activity is only located in the carboxy-terminal domain
   Biochem Biophys Res Commun179, 1587-1592. PubMed  Europe PubMed
1990
4. [YEAR:15-5-1990]Eisenberg,S.P., Hale,K.K., Heimdal,P. and Thompson,R.C.
   Location of the protease-inhibitory region of secretory leukocyte protease inhibitor
   J Biol Chem265, 7976-7981. PubMed  Europe PubMed
5. [YEAR:19-4-1990]Kramps,J.A., van Twisk,C., Appelhans,H., Meckelein,B., Nikiforov,T. and Dijkman,J.H.
   Proteinase inhibitory activities of antileukoprotease are represented by its second COOH-terminal domain
   Biochim Biophys Acta1038, 178-185. PubMed  Europe PubMed DOI
6. Meckelein,B., Nikiforov,T., Clemen,A. and Appelhans,H.
   The location of inhibitory specificities in human mucus proteinase inhibitor (MPI): separate expression of the COOH-terminal domain yields an active inhibitor of three different proteinases
   Protein Eng3, 215-220. PubMed  Europe PubMed